| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/10/264:05 PM | -$0.45 | -$0.73GAAP | -62.2% | -35% | $10.4M | $0 | -100% | — | |
| Q2 '26 | 8/13/264:05 PM | -$0.58 | -$0.70GAAP | -20.7% | -23% | — | $0 | — | — | |
| Q1 '26 | 5/12/264:01 PM | -$0.54 | -$0.59GAAP | -9.3% | -11% | $25.2M | $0 | -100% | — | |
| Q4 '25 | 3/12/264:01 PM | -$0.53 | -$0.62GAAP | -17.0% | -287% | $1.7M | $0 | -100% | -100% | |
| Q3 '25 | 11/10/254:01 PM | -$0.54 | -$0.54GAAP | 0.0% | -42% | $1.2M | $0 | -100% | -100% | |
| Q2 '25 | 8/11/254:05 PM | -$0.48 | -$0.57GAAP | -18.7% | -63% | $1.6M | $0 | -100% | -100% | |
| Q1 '25 | 5/13/254:05 PM | -$0.32 | -$0.53GAAP | -65.6% | -71% | $3.2M | $0 | -100% | -100% |
GAAP = diluted EPS as filed with the SEC.